BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2011
View Archived Issues
RVX-208 does not significantly raise ApoA-I levels in ASSERT trial
Read More
Overall success rate of clinical drug development is 9%
Read More
Taiwanese scientists use [18F]-FDG PET to predict survival of patients with OSCC
Read More
Antiestrogen therapy for breast cancer may reduce risk of mortality from lung cancer
Read More
Vernalis presents new inhibitors of serine/threonine-protein kinase Chk1
Read More
Astellas reviews highlights of third quarter fiscal year 2010
Read More
New cytotoxic chalcone derivatives claimed by Adamed
Read More
Pfenex and Boehringer Ingelheim form strategic alliance for novel technology
Read More
Eli Lilly achieves milestone in Mirror Portfolio venture
Read More
New modulators claimed of metabotropic glutamate mGlu4 receptor
Read More
Irish scientists patent new metal complexes for cancer therapy
Read More
GSK divulges new agents for treatment of HIV infections
Read More
INTERCEPT-prepared plasma receives FDA orphan drug status in TTP
Read More
Endo Pharma and Bioniche begin enrollment in second phase III trial of Urocidin
Read More
Aeolus receives U.S. government contract to develop AEOL-10150 for lung ARS
Read More
Spanish Ministry of Health grants full reimbursement for Sativex in MS-related spasticity
Read More
Rockwell Medical initiates PRIME trial examining use of SFP in hemodialysis
Read More
PharmaGap contracts NLI to develop liposomal GAP-107B8 formulation
Read More
Astellas and Aveo sign agreement for tivozanib outside of Asia
Read More
NICE recommends use of Vidaza for treatment of MDS and AML
Read More
Pro-Pharma receives final tranche from QTDP grant
Read More
Enrollment begins in phase II trial of carboplatin and paclitaxel plus Reolysin in pancreatic cancer
Read More
Phase III Chinese trial of Dromos in peripheral arterial diseases meets primary endpoint
Read More
